(Q44801683)

English

Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy

scientific article published on 21 December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy (English)

1 reference

Europe PubMed Central

6 December 2017

0 references

author name string

Mariko Horiike

1

1 reference

Europe PubMed Central

6 December 2017

Shingo Iwami

2

1 reference

Europe PubMed Central

6 December 2017

Makoto Kodama

3

1 reference

Europe PubMed Central

6 December 2017

Akihiko Sato

4

1 reference

Europe PubMed Central

6 December 2017

Yuji Watanabe

5

1 reference

Europe PubMed Central

6 December 2017

Mika Yasui

6

1 reference

Europe PubMed Central

6 December 2017

Yuki Ishida

7

1 reference

Europe PubMed Central

6 December 2017

Takeshi Kobayashi

8

1 reference

Europe PubMed Central

6 December 2017

Tomoyuki Miura

9

1 reference

Europe PubMed Central

6 December 2017

Tatsuhiko Igarashi

10

1 reference

Europe PubMed Central

6 December 2017

language of work or name

0 references

publication date

21 December 2011

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

423

1 reference

Europe PubMed Central

6 December 2017

2

1 reference

Europe PubMed Central

6 December 2017

107-118

1 reference

Europe PubMed Central

6 December 2017

Sensitivity/resistance profile of a simian immunodeficiency virus containing the reverse transcriptase gene of human immunodeficiency virus type 1 (HIV-1) toward the HIV-1-specific non-nucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Kinetics of Lymphocyte Proliferation during Primary Immune Response in Macaques Infected with Pathogenic Simian Immunodeficiency Virus SIVmac251: Preliminary Report of the Effect of Early Antiviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Follicular dendritic cell contributions to HIV pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Re-emergence of HIV after stopping therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

T cell dynamics in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

CLINICAL CALORIMETRY

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Bootstrap Methods: Another Look at the Jackknife

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Simultaneous determination of ritonavir and saquinavir, two human immunodeficiency virus protease inhibitors, in human serum by high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Susceptibilities of Simian Immunodeficiency Virus to Protease Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Establishment of a high production system for AIDS retroviruses with a human T-leukemic cell line Molt-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Human immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Rapid dissemination of a pathogenic simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Dose translation from animal to human studies revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

HIV chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

A simple and rapid method for preliminary evaluation of in vivo efficacy of anti-HIV compounds in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Follicular dendritic cells and human immunodeficiency virus type 1 transcription in CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.024

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2011.11.024

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44801683&oldid=2043388713"